SBIR/STTR Research Award

Machine vision guided robotics for automated microinjections into fruit fly embryos

Award identifier a084fa8c50e081b136084133bd65b4216d137d57afb59da129dbbf32dcf6ed97Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$294,543

Program and phase

SBIR · Phase I

Award year

2024

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Objective Biotechnology, INC.
Proposal award date
2024-09-01
Contract end date
2025-08-31
UEI
GN5KBQRNCBA9
Solicitation number
PA23-230
Topic code
OD

Research abstract

PROJECT SUMMARY Objective Biotechnology is a spin-out from the University of Minnesota that is pioneering the use of machine vision guided robots for automating precise microbiology procedures such as microinjection. Drosophila melanogaster (fruit fly) is a model organism extensively used in both basic and clinical research. A key challenge in Drosophila biological research is the bottleneck of generating and maintaining transgenic lines of flies. Traditionally, transgenesis involves skilled technicians performing intricate and precise microinjection procedures repeatedly. However, Objective Biotechnology Inc. has introduced an innovative solution - a machine vision guided robot designed to automate the microinjection process for Drosophila melanogaster embryos. This technology can also be adapted for use with various other organisms. This robot eliminates the need for manual microinjection protocols, which are operator-dependent, time-consuming, and require significant training. The robot uses machine learning (ML) models trained to detect individual embryos on agar plates and guides microinjection needles to perform microinjections at specific locations in each detected embryo. This robot can be operated by individuals with no prior experience and surpass human capabilities in terms of microinjection speed, performing at a rate six times faster than humans. In AIM 1 of this proposal, we will evaluate the efficacy and generalizability of the Autoinjector technology for transgenesis across a wide spectrum of Drosophila experiments. This involves testing and refining the automated microinjection process for different genetic backgrounds, microinjection locations, microinjectant compositions, construct sizes, auxiliary plasmids or transgenes, as well as various operational variables such as embryo laying conditions, culture media, DNA concentration, and solution viscosity. AIM 2 of this proposal we will innovate the ML algorithms to address two identified failure modes in the automated microinjection process. These failure modes are (1) the inability to detect individual embryos when they are clustered together on the embryo collection plates and (2) the clogging of pipettes during automated microinjection. We will develop ML-guided robotic algorithms to mitigate these issues and improve the overall performance of the system.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

2 SBIR/STTR records share this UEI (2024–2025). Reported award amounts total $711,468. Reported amounts are not federal obligations.

Phases: Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.